© 2022 MJH Life Sciences and Contagion Live. All rights reserved.
© 2022 MJH Life Sciences™ and Contagion Live. All rights reserved.
December 20, 2020
February 11, 2020
Readmission rates for patients receiving OPAT are reported to be as high as 20%, mostly due to catheter-related problems, adverse drug reactions, or worsening of the primary infection.
September's Top 5 Infectious Disease Stories
COVID-19 Vaccine Boosters: Roadblocks, the Future, and Communicating the Benefits to Patients
CDC Updates Pneumococcal Conjugate Vaccine Recommendations
Shionogi Reaches Endpoint for Phase 3 COVID-19 Pill